VitaNova Life Sciences (VNOV) EBIT (QoQ) (2017 - 2026)
VitaNova Life Sciences (VNOV) EBIT (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -335.09% |
| Jan 31, 2026 | -52.88% |
| Oct 31, 2025 | 405.70% |
| Jul 31, 2025 | -103.00% |
| Apr 30, 2025 | 894.04% |
| Jan 31, 2025 | 73.92% |
| Oct 31, 2024 | 237.84% |
| Jul 31, 2024 | -119.52% |
| Apr 30, 2024 | 3,811.95% |
| Jan 31, 2024 | 167.94% |
| Oct 31, 2023 | 63.89% |
| Jul 31, 2023 | -452.95% |
| Apr 30, 2023 | 75.09% |
| Jan 31, 2023 | -498.80% |
| Oct 31, 2022 | 106.84% |
| Jul 31, 2022 | 107.96% |
| Apr 30, 2022 | -210.68% |
| Jan 31, 2022 | 180.76% |
| Oct 31, 2021 | -186.01% |
| Jul 31, 2021 | 58.98% |